Clinical Trial Update: A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI) [Phase 1]

View source ↗

Summary

Phase 1 proof-of-concept trial evaluating exosomes derived from human mesenchymal stem cells for premature ovarian insufficiency is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diminished Ovarian Reserve
• Premature Ovarian Insufficiency

Drugs mentioned

• Mesenchymal stem cell-derived exosome therapy (exosome therapy)

Snippet

Sponsor: Vitti Labs, LLC | Conditions: Premature Ovarian Insufficiency, Diminished Ovarian Reserve | Phase 1 | Status: SUSPENDED